Explore more publications!
Anguilla Healthcare Digest
Got News to Share?

Anguilla Healthcare Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Healthcare Digest.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 8, 2025

International study offers new path to reduce spinal taps in young infants with fevers
December 8, 2025

International study offers new path to reduce spinal taps in young infants with fevers

Indeterminate GlobeNewswire
March Biosciences Presents Positive Interim Clinical Data from Phase 2 Trial of MB-105 CD5 CAR-T Cell Therapy at ASH 2025 Annual Meeting
December 8, 2025

March Biosciences Presents Positive Interim Clinical Data from Phase 2 Trial of MB-105 CD5 CAR-T Cell Therapy at ASH 2025 Annual Meeting

Indeterminate GlobeNewswire
Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial
December 8, 2025

Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial

Indeterminate GlobeNewswire
Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML
December 8, 2025

Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML

Indeterminate GlobeNewswire
DANDY® CELERY OFFERS SHOPPERS 26 CHANCES TO WIN WITH ANNUAL PROMOTION
December 8, 2025

DANDY® CELERY OFFERS SHOPPERS 26 CHANCES TO WIN WITH ANNUAL PROMOTION

Indeterminate GlobeNewswire
Global Peptide Synthesis Market Set to Reach USD 1.41 Billion by 2029 | MarketsandMarkets™
December 8, 2025

Global Peptide Synthesis Market Set to Reach USD 1.41 Billion by 2029 | MarketsandMarkets™

Indeterminate GlobeNewswire
Wake Radiology’s Dr. Monica Reddy Recognized as a National Leader on the Radiology Business Forty Under 40 List
December 8, 2025

Wake Radiology’s Dr. Monica Reddy Recognized as a National Leader on the Radiology Business Forty Under 40 List

Indeterminate GlobeNewswire
SafeSpace Global (SSGC) Announces Strategic Partnership With 911inform to Transform School Safety Across America
December 8, 2025

SafeSpace Global (SSGC) Announces Strategic Partnership With 911inform to Transform School Safety Across America

Indeterminate GlobeNewswire
UMC Utrecht Selects PathAI’s AISight® Dx to Accelerate Research on AI Pathology Algorithms
December 8, 2025

UMC Utrecht Selects PathAI’s AISight® Dx to Accelerate Research on AI Pathology Algorithms

Indeterminate GlobeNewswire
John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scientific Conference
December 8, 2025

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scientific Conference

Indeterminate GlobeNewswire
Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray
December 8, 2025

Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray

Indeterminate GlobeNewswire
Autolus Therapeutics Presents Initial Clinical Data in Pediatric r/r B-ALL Patients and Other Oncology Data at the American Society of Hematology (ASH) Annual Meeting 2025
December 8, 2025

Autolus Therapeutics Presents Initial Clinical Data in Pediatric r/r B-ALL Patients and Other Oncology Data at the American Society of Hematology (ASH) Annual Meeting 2025

Indeterminate GlobeNewswire
rYojbaba Subsidiary Sakai Seikotsuin Serves as an Official Trainer at the 2025 Taipei Wake Open
December 8, 2025

rYojbaba Subsidiary Sakai Seikotsuin Serves as an Official Trainer at the 2025 Taipei Wake Open

Indeterminate GlobeNewswire
Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer
December 8, 2025

Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer

Indeterminate GlobeNewswire
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
December 8, 2025

IRADIMED Announces Special Cash Dividend of $0.50 Per Share

Indeterminate GlobeNewswire
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
December 8, 2025

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

Indeterminate GlobeNewswire
Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma
December 8, 2025

Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma

Indeterminate GlobeNewswire
NetraAI Study Accepted for Publication in npj Digital Medicine, Part of the Nature Portfolio
December 8, 2025

NetraAI Study Accepted for Publication in npj Digital Medicine, Part of the Nature Portfolio

Indeterminate GlobeNewswire
Moleculin Announces New Annamycin Collaboration in Brain Tumors
December 8, 2025

Moleculin Announces New Annamycin Collaboration in Brain Tumors

Indeterminate GlobeNewswire
RESTEM Announces First-Patient-Dosed in the Phase 1/2a Study of Restem-L in Facioscapulohumeral Muscular Dystrophy
December 8, 2025

RESTEM Announces First-Patient-Dosed in the Phase 1/2a Study of Restem-L in Facioscapulohumeral Muscular Dystrophy

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions